The result rates may vary from person to person due to lifestyle or food intake, it would be better to continue until you get your desired results
Maximum Weight Loss Potential (Future) Amycretin Phase 1b/2a showed up to 24.3% weight loss at 36 weeks with no plateau, suggesting even greater loss with longer treatment
Fox SR, Jong MT, Casanova J, Ye ZS, Stanley F, Samuels HH
In summary, 2025 marks a turning point in MPNST research, with precision oncology, immunotherapy combinations, and early detection technologies offering hope in a disease long defined by limited treatment options and poor outcomes
Short-term temperature exposure during travel or transport is generally less concerning than prolonged storage outside recommended ranges